Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Jul 6;111(2):152-5.
doi: 10.1161/CIRCRESAHA.112.272526.

Created equal? The many facets of cell reprogramming

Annarosa Leri, Jan Kajstura
Editorial

Created equal? The many facets of cell reprogramming

Annarosa Leri et al. Circ Res. .

Retraction in

Expression of concern in

  • Expression of Concern.
    [No authors listed] [No authors listed] Circ Res. 2019 Jan 18;124(2):e4-e5. doi: 10.1161/RES.0000000000000241. Circ Res. 2019. PMID: 30582460 No abstract available.
  • Expression of Concern.
    [No authors listed] [No authors listed] Circulation. 2019 Jan 15;139(3):e5-e6. doi: 10.1161/CIR.0000000000000639. Circulation. 2019. PMID: 30615475 No abstract available.
No abstract available

PubMed Disclaimer

Figures

Figure
Figure. Epigenetics of human C-kit–positive cardiac stem cells with significant vasculogenic potential (vCSCs)
A, Chromatin structure predictive of a multipotent state carries a bivalent configuration of histones, characterized by activating and inactivating marks. Activating marks include acetylation of histones H3 and H4 at lysine residues and methylation of histone H3 at lysine 4. Inactivating marks include methylation of histone H3 at lysine residues. B through E, H3K27me3, H3K4me2, H3K9me2, and H3K9Ac were detected by immunocytochemistry and confocal microscopy in human vCSCs (c-kit, green; KDR, white). H3K27me3 (B: red), H3K4me2 (C: red), H3K9me2 (D: red), and H3K9Ac (E: red) were localized in the nuclei of vCSCs.
See this image and copyright information in PMC

Comment on

References

    1. Tosh D, Slack JM. How cells change their phenotype. Nat Rev Mol Cell Biol. 2002;3:187–194. - PubMed
    1. Thal MA, Krishnamurthy P, Mackie AR, Hoxha E, Lambers E, Verma S, Ramirez V, Qin G, Losordo DW, Kishore R. Enhanced angiogenic and cardiomyocyte differentiation capacity of epigenetically reprogrammed mouse and human endothelial progenitor cells augments their efficacy for ischemic myocardial repair. Circ Res. 2012;111:180–190. - PMC - PubMed
    1. Kawamoto A, Katayama M, Handa N, et al. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells. 2009;27:2857–2864. - PubMed
    1. Losordo DW, Henry TD, Davidson C, et al. for the ACT34-CMI Investigators. Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res. 2011;109:428–436. - PMC - PubMed
    1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–967. - PubMed

MeSH terms